Regulatory Path Retatrutide is not yet approved for the treatment of obesity or type 2 diabetes
For retatrutide, this means approximately 24 to 30 days, or roughly 4 weeks
As employee interest in GLP-1 medications grows, employers may see more questions about insurance coverage, prior authorization, costs, and long-term use
Contextualize heart rate changes within the broader cardiovascular picture
We've been using them safely in medicine for decades nicotine replacement, hormone replacement therapy (HRT), some pain medications, motion sickness drugs, certain heart treatments
By decreasing appetite, GLP-1 injections make it easier to follow a reduced-calorie diet without feeling constantly hungry or deprived